In The Cancer Genome Atlas (TCGA) dataset, 14% of invasive bladder cancers have mutations in CDKN1A encoding the cyclin-dependent kinase inhibitor p21CIP1 [24]. The gene discussed is CDKN1A; the disease is urinary bladder cancer.